Calidi Biotherapeutics, Inc. (CLDI)
0.185
0.00 (0.00%)
USD |
NYAM |
May 29, 16:00
0.1948
+0.01
(+5.30%)
After-Hours: 20:00
Calidi Biotherapeutics Total Assets (Quarterly) : 9.591M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| IN8bio, Inc. | 26.26M |
| Connect Biopharma Holdings Ltd. | 60.07M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.656M |
| Shareholders Equity (Quarterly) | 4.935M |
| Debt to Equity Ratio | 0.4573 |
| Current Ratio | 1.917 |
| Net Debt Paydown Yield | 33.96% |